Patents by Inventor Stéphanie Beq

Stéphanie Beq has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-HUMAN CXCR5 ANTIBODY AND USES THEREOF
    Publication number: 20240158517
    Abstract: The invention provides monoclonal antibodies and antigen-binding fragments thereof specific for (human) CXCR5, and methods of using the same to treat Sjögren syndrome, certain cancers and autoimmune disorders, including combination therapy.
    Type: Application
    Filed: March 9, 2022
    Publication date: May 16, 2024
    Inventors: Liang Schweizer, Sami Ellouze, Ayrin Kök Harunova, Stéphanie Beq, Nicola Arturo Aldo Beltraminelli, Qian Zhang, Francisco Adrian, Yun-Yueh Lu
  • HCV IMMUNOTHERAPY
    Publication number: 20140377218
    Abstract: The invention relates to the use of Interleukin-7 (IL-7), for treating hepatitis C in a patient infected with hepatitis C virus, wherein said patient has been treated or is being treated with an antiviral agent or a combination of antiviral agents that reduces viral load.
    Type: Application
    Filed: August 2, 2012
    Publication date: December 25, 2014
    Applicant: CYTHERIS
    Inventors: Michel Morre, Brigitte Assouline, Therese Croughs, Pierre Demol, Stephanie Beq